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Abstract
Turbidity (absorbance at 470 nm) measurements revealed human serum low density lipoprotein (LDL) to cause, within a
few minutes and at physiological pH and [NaCl], the aggregation of liquid crystalline large unilamellar liposomes (LUVs) of
dimyristoylphosphatidylglycerol (DMPG). No evidence for concomitant lipid or aqueous contents mixing was obtained with
fluorescent assays for these processes, in keeping with the lack of fusion of LUVs. Involvement of apoB is implicated by the
finding that tryptic digestion of LDL abrogates its ability to cause aggregation. Aggregation is not caused by VLDL, HDL2,
or HDL3. Interestingly, also oxidised LDL failed to aggregate DMPG vesicles. Aggregation of DMPG LUVs by LDL did
depend on the ionic strength of the medium as well as on the phase state of the lipid. More specifically, below the main
transition temperature Tm maximal aggregation was seen in the presence of 25^100 mM NaCl, whereas slightly higher (up to
150 mM) [NaCl] were required when TsTm. Aggregation due to LDL was also observed for dimyristoylphosphatidylserine
as well as for dipalmitoylphosphatidylglycerol LUVs, whereas liposomes composed of either unsaturated acidic
phospholipids or different phosphatidylcholines were not aggregated. Involvement of electrostatic attraction between the
acidic phosphate of DMPG and cationic residues in apoB is suggested by the finding that increasing the content of
dimyristoylphosphatidylcholine (DMPC) in DMPG liposomes reduced their aggregation and at XDMPC = 0.50 no response
was evident. Notably, increasing the mole fraction of 1-palmitoyl-2-oleyl-PG (POPG) in DMPG LUVs progressively reduced
their aggregation by LDL and at XPOPG = 0.50 there was complete inhibition. The latter effect of POPG is likely to be due to
augmented hydration of the unsaturated lipid constituting a barrier for the contact between apoB and the vesicle surface. In
keeping with this view, the presence of the strongly hygroscopic polymer, poly(ethylene glycol) at 1% (by weight) enhanced
the aggregation and could partly reverse the inhibition by POPG. ß 1998 Elsevier Science B.V. All rights reserved.
0005-2736 / 98 / $19.00 ß 1998 Elsevier Science B.V. All rights reserved.
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Abbreviations: ANTS, 8-aminonaphthalene-1,3,6-trisulphonate; BSA, bovine serum albumin; DMPC, 1,2-dimyristoyl-sn-glycero-3-
phosphocholine; DMPG, 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol ; DMPS, 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine; DPPF,
1,2-dipalmitoyl-sn-glycero-3-phosphoethanol-N-thiocarbamoyl-5-£uorescein; DPPG, 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol ;
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1. Introduction
One of the most common causes of death in in-
dustrial countries is occlusion of blood vessels due to
atherosclerosis, resulting from the formation of lipid
plaques in the arterial walls. High blood levels of
cholesterol correlate with atherosclerosis and the for-
mer is directly related to the contents of cholesterol
and saturated fat in the diet. Atherosclerosis is, how-
ever, a multifactorial disease which also involves a
strong genetic component [1].
Most of the plasma cholesterol is present in low
density lipoproteins (LDL), an essential component
of the plasma lipid transport system. The metabolism
of LDL involves recognition of its protein moiety
apolipoprotein B-100 by speci¢c receptors, followed
by endocytotic uptake. Cholesteryl esters of the in-
ternalised particles are thereafter hydrolysed in lyso-
somes and the liberated cholesterol and fatty acids
reutilised by the cells [2^4]. In addition, oxidation of
LDL has been shown to be an important determi-
nant for its catabolic cellular processing [5], and to
be associated with an enhanced risk for the develop-
ment of atherosclerosis [6,7]. Lack of the LDL recep-
tors causes the highly elevated levels of plasma LDL
in the familial type-II hypercholesterolaemia [8^11], a
disorder associated with an enhanced development of
atherosclerotic lesions [6,12^14]. While this defect as
well as epidemiological studies provide clear evidence
for the importance of high plasma LDL concentra-
tions in augmenting cholesterol deposition into the
arterial intima the exact molecular level events of this
process have remained unresolved. To this end, both
smoking and high blood pressure represent addition-
al, independent risk factors for atherosclerosis
[15,16]. The molecular mechanism by which the latter
two enhance cholesterol accumulation into athero-
sclerotic lesions are unknown.
Both extracellular and cellular pathways for the
accumulation of LDL cholesterol into atheroma
have been postulated and are both supported by
¢ndings from in vitro experiments, cell studies, as
well as by histological data on diseased tissues. Smith
[17] proposed atheroma formation to be an extra-
cellular process, initiated by the binding of LDL to
glycosaminoglycans, elastin, and proteoglycans [18^
21]. Subsequently, this binding would be followed by
the aggregation and fusion of LDL so as to result in
the formation of lipid droplets [22] and the accumu-
lation into the intima of deposits of cholesterol and
cholesteryl esters, liposomes enriched in free choles-
terol, and cholesteryl ester enriched lipoproteins
[23,24]. Upon progression of the lesions, further ac-
cumulation of cholesterol into the atheroma core en-
sues, so as to ¢nally result in their rupture [25]. When
such rupture occurs in the coronary arteries, this
further causes thrombus formation and heart attack
[26].
The proposed intracellular pathway for atheroma
formation involves the fusion of LDL particles after
their binding to the negatively charged sulphated gly-
cosaminoglycans of the arterial intima [27^29].
Thereafter, these aggregated and fused LDLs should
be taken up by macrophages, which then become
foam cells, characteristic to the intima a¡ected by
atherosclerotic lesions [30]. The above two mecha-
nisms are not mutually exclusive and could both con-
tribute to lipid accumulation into arterial walls. In-
terestingly, also vigorous mixing by vortexing (i.e.
exposure to an excess of an air/water interface)
causes the aggregation of LDL in vitro [31,32]. En-
hanced uptake of such aggregated LDL by macro-
phages has been recently demonstrated [33]. This ag-
gregation is prevented by HDL and possible linkage
to the antiatherogenic e¡ect of the latter lipoprotein
was suggested [34].
Both lipid^lipid and lipid^protein interactions in
LDL have been extensively investigated by a variety
of techniques, including di¡erential scanning calo-
rimetry [35^37]. Likewise, interactions of LDL with
various proteins and cell types have been studied
[38^41]. While the association of cholesterol-contain-
ing liposomes with HDL and LDL has been reported
[42^44] our knowledge on the interaction of LDL
with lipid surfaces is still limited. Coprecipitation of
cholesteryl ester/phosphatidylcholine microemulsions
with LDL in vitro has been shown [45]. This complex
formation could be prevented by apolipoprotein A-I,
and did not depend on the unsaturation or satura-
tion of the phospholipid. In another study [46], it
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was shown that tryptic digestion of LDL abolished
its coprecipitation with cholesteryl ester/phospha-
tidylcholine microemulsions.
Electrostatic interaction between LDL and nega-
tively charged glycosaminoglycans is well established
[27^29] and is likely to be mediated by positively
charged clusters of lysine and arginine of apoB
[47]. However, we are not aware of any studies on
possible, similarly electrostatically mediated inter-
actions between LDL and acidic phospholipids.
A recent investigation revealed incubation of
LDL with an excess of cardiolipin to result in
an enhanced uptake of the lipoproteins by macro-
phages [48]. We demonstrate here that LDL, but
not HDL or VLDL, causes, under proper conditions,
an extensive aggregation of LUVs composed of
saturated acidic phospholipids. Possible mechanism
as well as physiological and pathological signi¢cance
of the major ¢ndings of the study are brie£y dis-
cussed.
2. Materials and methods
2.1. Materials
DMPG, DMPS, cholesterol, egg PG, POPG, PS
(from bovine brain), and bovine pancreatic trypsin
were from Sigma. DPPG was from Alexis (La«ufel¢n-
gen, Switzerland), DMPC from Princeton Lipids
(Princeton, NJ, USA), PPDPG from KpV Bioware
(Espoo, Finland), and DPPF from Molecular Probes
(Eugene, OR, USA). PEG (average molecular weight
of 6000) was from Fluka. The purity of the above
lipids was veri¢ed by thin-layer chromatography on
silica gel-coated plates (Merck, Darmstadt, Ger-
many) using chloroform/methanol/water/ammonia
(65:20:2:2, by volume) as the solvent system. Ex-
amination of the plates after iodine staining and,
when appropriate, upon UV-illumination revealed
no impurities. For saturated phospholipids also
di¡erential scanning calorimetry (DSC) scans were
performed using MLVs and gave endotherms with
peak maxima and enthalpies identical to those in
literature. Phospholipid concentrations were deter-
mined as organic phosphate by the method of Bart-
lett [49].
2.2. Isolation of plasma lipoproteins
Human VLDL (density fraction 6 1.006 g/ml),
LDL (d = 1.019^1.063 g/ml), total HDL (d = 1.063^
1.215 g/ml), HDL2 (d = 1.063^1.125 g/ml), and
HDL3 (d = 1.125^1.215 g/ml) were isolated by
sequential ultracentrifugation [50]. Comparison of
LDL from single donors revealed essentially no dif-
ferences. Accordingly, pooled plasma from healthy
donors was used for lipoprotein isolation. For re-
moval of KBr LDL was further subjected to gel ¢l-
tration on a Sepharose CL 4B (1.6U60 cm) column
eluted at 4‡C in 20 mM HEPES, 150 mM NaCl, 0.1
mM EDTA, pH 7.4. Protein concentrations were de-
termined by the method of Bradford [51] using bo-
vine serum albumin as a standard. Amounts of LDL
are expressed as Wg of protein. The above density
range continues to be widely used (e.g. [52,53]) for
the isolation of LDL. Notably, although some size
heterogeneity of the isolated lipoproteins is antici-
pated, this is unlikely to interfere with the present
¢ndings. For some experiments, LDL was dialysed
against NaCl-free bu¡er. The mobility and purity of
LDL was checked by electrophoresis in 1% agarose
gel at pH 8.6 [54]. Polyacrylamide gel electrophoresis
performed in the presence of 8% sodium dodecyl
sulphate revealed no evidence for degradation of
apoB.
2.3. Tryptic digestion of LDL
LDL (0.6 mg protein/ml) was incubated with 2%
(w/w) bovine pancreatic trypsin for 16 h at 37‡C
while an identical sample without trypsin served as
a control [55]. Trypsin-treated LDL and control
LDL were then adjusted to 1 mM PMSF and frac-
tionated on a column (1.5U23 cm) of Sephadex G-
75. The column was equilibrated and eluted with 20
mM HEPES, 150 mM NaCl, 0.1 mM EDTA, pH
7.4. Fractions of 1 ml were collected and assayed
for protein. Those containing LDL were pooled
and used in further experiments.
2.4. Oxidation of LDL
LDL was dialysed against 20 mM HEPES, 150
mM NaCl, pH 7.4 at 4‡C and its oxidation by cop-
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per carried out at 37‡C for 24 h in loosely capped
glass vials [56]. Concentration of LDL was 2.0 mg
protein/ml and [Cu2] was 20 WM. Oxidation was
terminated by the addition of EDTA in excess of
the Cu2 concentration. Electrophoresis in 1% agar-
ose gel was performed to verify lipoprotein oxidation
[54]. Oxidised LDL was ¢nally dialysed against 20
mM HEPES, 150 mM NaCl, 0.1 mM EDTA, pH
7.4. Control LDL went through the same procedure,
but without exposure to copper.
2.5. Preparation of liposomes
Lipids were dissolved in chloroform and mixed to
obtain the desired compositions. They were subse-
quently dried under a gentle stream of nitrogen and
maintained under reduced pressure for at least 2 h to
ascertain removal of residual solvent. Unless other-
wise indicated, the dry lipid was then hydrated in 20
mM HEPES, 150 mM NaCl, 0.1 mM EDTA, pH
7.4, to yield a ¢nal concentration of 1 mg/ml. In
order to obtain large unilamellar vesicles, the hy-
drated lipids were extruded [57] through 0.1 Wm pol-
ycarbonate ¢lters (Nuclepore, Pleasanton, CA) with
a LiposoFast low pressure homogeniser (Avestin, Ot-
tawa, Canada). The liposomes thus obtained were
stored at 4‡C and used within 2 days.
2.6. Absorbance measurements
Aggregation of lipid vesicles was monitored by
measuring absorbance at 470 nm (A470) using a Shi-
madzu Graphicord spectrophotometer and cuvettes
with an optical path of 1 cm. The cuvette compart-
ment was thermostated with a circulating waterbath
either at 15 or 29‡C, or as indicated. Prior to the
addition of the lipoproteins, the vesicles were allowed
to equilibrate for 15 min. Unless otherwise stated,
the data shown were corrected for the background
absorbance due to LUVs and the lipoproteins used,
i.e. the values shown represent increase in A470 due to
the aggregation of LUVs by LDL. The background
absorbances measured for LUVs (typically 75 WM
total phospholipid) and LDL (6 Wg of protein per
ml) were 0.002 and 0.003, respectively. Unless other-
wise indicated, the bu¡er was 20 mM HEPES, 150
mM NaCl, 0.1 mM EDTA, pH 7.4. In some experi-
ments, PEG (molecular weight of 6000) was included
to yield a ¢nal concentration of 1% by weight. This
[PEG] did not cause any aggregation of LDL or
DMPG LUVs as such.
2.7. Lipid mixing assay
Resonance energy transfer between two chromo-
phores (donor and acceptor) observed by steady state
£uorescence measurement allows their proximity to
be assessed [58]. The radiationless transfer of quanta
by dipole^dipole coupling requires the emission spec-
trum of the donor dye to overlap with the absorption
spectrum of the acceptor. Resonance energy transfer
assays for monitoring lipid mixing upon vesicle fu-
sion have been devised (e.g. [59]). We utilised, for
this purpose, the spectral overlap of excimer emission
of the pyrene-labelled lipid analogue, PPDPG and
the absorption of the £uorescein-labelled phospholip-
id derivative, DPPF [60]. Accordingly, if the probes
reside within the same membrane, complete disap-
pearance of the excimer band centered at approxi-
mately 480 nm results. In contrast, for a mixture of
two populations of liposomes, one containing
PPDPG and the other DPPF, a strong excimer emis-
sion remains. Complete lipid mixing between the two
vesicle populations causes quenching of excimer
emission (data not shown).
Emission spectra of PPDPG- and/or DPPF-la-
belled DMPG liposomes were recorded with a Perkin
Elmer LS 50B spectro£uorometer connected to a
486, 66 MHz computer. The instrument was oper-
ated and the data analysed using the dedicated soft-
ware from Perkin Elmer. Excitation wavelength was
345 nm, while emission spectra in the range of 360^
550 nm were measured. Bandpasses of 2.5 and 3 nm
were used for the excitation and emission beams,
respectively. Prior to the addition of the indicated
lipoproteins, liposomes were allowed to equilibrate
for 15 min in a magnetically stirred four-window
quartz cuvette in a holder thermostated with a circu-
lating waterbath at 29‡C.
2.8. Contents mixing assay
The ANTS/DPX assay described by Ellens et al.
[61] for observing mixing of the aqueous contents of
LUVs was employed. This method is based on the
collisional quenching of ANTS £uorescence by DPX
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upon merging of the aqueous cavities during fusion
of the two vesicle populations. In brief, DMPG
LUVs encapsulating either: (a) 25 mM ANTS (in
40 mM NaCl, 10 mM TES, pH 7.4); (b) 90 mM
DPX (in 10 mM TES, pH 7.4); or (c) 12.5 mM
ANTS, and 45 mM DPX (in 20 mM NaCl, 10 mM
TES, pH 7.4) were prepared. The hydrated lipids
were extruded as described above and thereafter cen-
trifuged for 15 min at 10 000Ug to remove any re-
maining large, multilamellar liposomes. The ANTS/
DPX ratios of 1:1 and 1:0.5 were used for fusion
assays. Liposomes with coencapsulated ANTS and
DPX were used to set £uorescence to zero. Fluores-
cence intensities were measured with an SLM 4800S
spectro£uorometer using excitation and emission
wavelengths of 360 and s 530 nm, respectively. Ex-
periments were performed at 29‡C in 100 mM NaCl,
5, mM TES, 0.1 mM EDTA, pH 7.4.
3. Results
3.1. Aggregation of DMPG LUVs by LDL
In the course of our studies on the lipid-binding
properties of human plasma LDL, we observed this
lipoprotein to produce at physiological pH and
[NaCl] a rapid aggregation of liquid crystalline
DMPG liposomes (Fig. 1A). Measured as a function
of time, the increase in absorbance was ¢rst preceded
by a lag period of up to 15 min, whereafter turbidity
increased rapidly, reaching a plateau within approx-
imately 60 min. We did not characterise, at this
stage, the kinetics of aggregation in more detail.
The lag time seems to vary between 0 to 15 min
and it appears to be somewhat dependent on the
particular vesicle as well as LDL preparation used.
As expected, increasing DMPG concentrations en-
hanced the rate of aggregation (Fig. 1B). Likewise,
using higher concentration of LDL reduced the lag
time. Interestingly, aggregation of DMPG by LDL is
strongly in£uenced by the phase state of this lipid
and less increase in turbidity was observed when
measured at 15‡C, i.e. below the main phase transi-
tion temperature Tm (= 23.5‡C) of DMPG (Fig. 1B).
Similar observation has been made for the associa-
tion of apolipoprotein A-I with this phospholipid
[62,63].
The dependency on the liquid crystalline state of
the liposomes is clearly seen in Fig. 2, which illus-
Fig. 1. (A) Aggregation of DMPG liposomes by increasing concentrations of LDL. DMPG liposomes (75 WM) and LDL (up to 75 Wg
of protein) were incubated in a total volume of 1 ml for 45 min at 29‡C (F), whereafter absorbance at 470 nm was measured. Bu¡er
was 20 mM HEPES, 150 mM NaCl, 0.1 mM EDTA, pH 7.4. (B) The time courses of the aggregation of liquid crystalline and gel
state DMPG LUVs. LDL (6 Wg/ml) was added to a solution of DMPG LUVs (75 WM) either at 15‡C (E) or 29‡C (F) while changes
in A470 were monitored as a function of time. Enhanced aggregation of DMPG LUVs either at higher lipid concentration (225 WM,
b) or using higher concentration of LDL (20 Wg/ml, a) at 29‡C was evident. Conditions were otherwise as described for (A).
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trates the aggregation of DMPG LUVs by LDL as a
function of lipid concentration, both below as well as
above Tm. Although the inclusion of LDL does in-
crease the absorbance of gel state DMPG liposomes,
their aggregation is strongly augmented above Tm
and the values of A470 for liquid crystalline DMPG
LUVs were maximally approximately 10-fold higher
than those measured below Tm. Due to the well-
known electrostatic interaction between LDL and
sulphated glycosaminoglycans [18^21], it was readily
anticipated that also the aggregation of the acidic
DMPG vesicles by this lipoprotein described here
would involve coulombic forces. In keeping with
this notion, essentially no aggregation due to LDL
was evident for LUVs of the zwitterionic DMPC,
neither below nor above the main transition temper-
ature of this lipid (Fig. 2). Likewise, increasing the
content of DMPC in DMPG LUVs reduced in a
progressive manner their aggregation by LDL (see
below).
To check the presence of LDL in the aggregates
60 Wg of LDL and 840 nmol DMPG were incubated
at 29‡C for 60 min in a total volume of 1 ml of 20
mM HEPES, 150 mM NaCl, 0.1 mM EDTA, pH
7.4. The aggregate was sedimented by centrifugation
in small plastic vials using a table top centrifuge
(Eppendorf) and subsequently analysed for the con-
tent of protein. Nearly 70% LDL protein was recov-
ered in the pellet. In comparison, with DMPC no
aggregate was formed and LDL protein remained
soluble.
3.2. Lack of fusion of LUVs due to LDL
To investigate the possibility that the aggregation
of DMPG LUVs by LDL would be accompanied by
fusion of the vesicles we employed both lipid as well
as contents mixing assays. For the former purpose
we prepared liposomes labelled with either PPDPG
or DPPF. Subsequently, PPDPG-labelled and
DPPF-labelled DMPG vesicles were ¢rst mixed,
whereafter LDL was added and the emission spectra
of pyrene and £uorescein was monitored as a func-
tion of time (data not shown). Lipid mixing would be
Fig. 2. LDL-induced aggregation of DMPG and DMPC LUVs
at varying phospholipid concentrations. LDL (6 Wg/ml) was
added to DMPG (F,E) and DMPC (a,b) liposomes and A470
measured after a 45 min incubation either at 15‡C (open sym-
bols) or 29‡C (¢lled symbols). The values for DMPC at both
temperatures (a,b) were indistinguishable. The data shown are
corrected for the background values of absorbance due to in-
creasing concentrations of LUVs. Bu¡er was 20 mM HEPES,
150 mM NaCl, 0.1 mM EDTA, pH 7.4.
Fig. 3. Lack of aggregation of DMPG liposomes by trypsin-
treated and oxidised LDL. DMPG LUVs (75 WM) were incu-
bated with 6 Wg/ml of trypsin-treated LDL (F), or 20 Wg/ml of
oxidised LDL (b) at 29‡C and changes in A470 were monitored
as a function of time. For comparison, experiment with control
LDL (6 Wg/ml) prepared without trypsin digestion (E) is also
shown. Control LDL (20 Wg/ml) prepared without CuSO4 gave
result similar to that illustrated in Fig. 1B. Medium was 20 mM
HEPES, 150 mM NaCl, 0.1 mM EDTA, pH 7.4.
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evident as an e¡ective reduction in the intensity of
pyrene excimer emission Ie due to resonance energy
transfer to £uorescein [60]. However, intensities of
both pyrene monomer and excimer £uorescence
were only slightly decreased during a 1 h incubation
after the addition of LDL (data not shown). Like-
wise, during an incubation for 1 h at 29‡C the ex-
cimer/monomer emission intensity ratio for PPDPG-
labelled DMPG LUVs decreased from 0.215 to 0.210
in the absence and to 0.200 in the presence of LDL.
Accordingly, although LDL causes the aggregation
of DMPG LUVs, lipid mixing does not appear to
take place. To this end, the above results are com-
patible with our measurements revealing lack of
aqueous contents mixing [61] of DMPG liposomes
upon their aggregation by LDL (data not shown).
3.3. Role of apoB, comparison of di¡erent lipoproteins
and the e¡ect of albumin
Aggregation of DMPG LUVs appears to be a
rather speci¢c property of LDL and VLDL, total
HDL, and both HDL2 and HDL3 subclasses were
all essentially ine¡ective (data not shown). Intact
apoB seems to be required and proteolytic digestion
of LDL by trypsin [35] fully abolished its ability to
aggregate DMPG liposomes (Fig. 3). To this end,
also oxidation of LDL by copper [56] completely
abrogated the capability of LDL for lipid aggrega-
tion (Fig. 3).
While VLDL and HDL do not aggregate DMPG
vesicles, it was of interest to study their in£uence on
the aggregation of vesicles by LDL. Notably, the
LDL-induced aggregation of DMPG LUVs was ef-
fectively inhibited by HDL3 and to a lesser extent by
HDL2 and VLDL (Fig. 4A). Inhibition was depend-
ent on the amounts of lipoproteins added and at
smaller LDL/VLDL and LDL/HDL ratios progres-
sively attenuated aggregation of DMPG LUVs be-
came evident (data not shown). In this context, it is
of interest to note that HDL inhibits the aggregation
of LDL due to vigorous mixing (vortexing) while the
inhibitory mechanism is unclear [34].
We also investigated the e¡ect of bovine serum
albumin on the DMPG^LDL interaction (Fig. 4B).
When LDL was added to DMPG LUVs in the pres-
Fig. 4. Inhibition of LDL-induced aggregation of DMPG LUVs by HDL2, HDL3, or VLDL, and the e¡ect of BSA. (A) LDL (6 Wg)
and HDL2 (F), HDL3 (b), or VLDL (R) (6 Wg of each lipoprotein) were ¢rst mixed in bu¡er and subsequently (within 10 min) added
to DMPG LUVs (75 WM lipid) at 29‡C to yield a total volume of one ml, whereafter changes in A470 were monitored as a function
of time. As a control the aggregation of DMPG LUVs by LDL (6 Wg/ml) is depicted (P). (B) BSA was ¢rst added at 29‡C to
DMPG LUVs (75 WM lipid) to yield the indicated ¢nal concentrations. After 15 min LDL (6 Wg/ml) was included and A470 monitored
as a function of time. Concentrations of BSA were 0 (a), 1 (8), 6 (b), 12 (R), and 50 Wg/ml (F). Data for DMPG LUVs incubated
with BSA (12 Wg/ml, no LDL) are also shown (+). Bu¡er in both panels was 20 mM HEPES, 150 mM NaCl, 0.1 mM EDTA, pH 7.4.
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ence of BSA (up to 50 Wg/ml, ¢nal concentration)
aggregation was slightly faster, i.e. the lag time was
reduced (in this experiment from approximately 15 to
5 min). Up to highest concentration tested BSA did
not cause aggregation of LDL or DMPG as such.
The elucidation of the mechanism of this e¡ect of
BSA warrants further studies. However, it would
be compatible with BSA reducing water activity,
thus depleting part of the hydration layer of
DMPG and diminishing the energy barrier for the
binding of LDL to liposome surface, similarly to
the e¡ect of PEG (see below).
3.4. E¡ects of ionic strength, pH, and the content of
acidic phospholipid in LUVs
Thermal phase behaviour of DMPG is reasonably
well characterised (e.g. [64^66]). Unlike phosphatid-
ylserine or phosphatidic acid the PG headgroup
should be less prone to form intermolecular hydro-
gen bond networks. Furthermore, DMPG does not
form non-lamellar phases and its protonation ap-
pears to comply with the principles of membrane
electrostatics forwarded by Tra«uble [67]. Accord-
ingly, as the use of PG as a model acidic phospho-
lipid allows for a relatively unambiguous interpreta-
tion of the data in terms of changes in lipid
protonation [68] we chose this phospholipid for fur-
ther studies at this stage.
Experiments with LDL treated with trypsin re-
vealed the involvement of apoB in the aggregation
process. As described above, aggregation of DMPG
liposomes by LDL was evident at physiological
[NaCl] and pH. While the net charge of LDL is
negative the apoB-100 moiety of LDL contains
some positively charged clusters [47,69]. To explore,
in more detail, the role of electrostatics in the inter-
action of LDL with the acidic DMPG, we studied
the e¡ect of ionic strength on the aggregation both
below and above Tm of the phospholipid, at 15 and
29‡C, respectively (Fig. 5). In the absence of salt, no
aggregation of DMPG LUVs by LDL was observed,
regardless of the phase state of the lipid. Below Tm,
maximum aggregation is observed at 25^75 mM
NaCl, while above Tm optimum [NaCl] for aggrega-
tion is somewhat higher, between 100 and 125 mM
NaCl. Below Tm, the lipoprotein induced increase in
turbidity was abolished by 150 mM NaCl. In addi-
tion, above Tm, the aggregation of liposomes due to
LDL did depend on the ionic strength and while
considerable aggregation was still seen at physiolog-
ical [NaCl] concentrations exceeding this were inhib-
itory. Notably, once DMPG LUVs were aggregated
by LDL subsequent addition of salt up to 250 mM
failed to reverse the increase in turbidity and essen-
tially no decrease in A470 could be observed (data not
shown). This irreversibility was evident both below
as well as above the phase transition temperature of
this phospholipid.
As was already noted above (Fig. 2) DMPC LUVs
were not aggregated by LDL. This is also evident in
Fig. 6, illustrating progressive reduction in A470 upon
increase in the content of DMPC in DMPG lipo-
somes. Aggregation of the binary DMPG/DMPC
LUVs was sensitive to pH when varied in the range
of 5.0 to 7.4 (Fig. 6). More speci¢cally, neat DMPG
LUVs were aggregated slightly more e⁄ciently at pH
5 than at pHs 6. Compared to pH 7.4 higher
amounts of DMPC in DMPG LUVs were required
to prevent the aggregation at acidic pH. Interest-
ingly, acidic pH also prevented the inhibitory e¡ect
of POPG on the aggregation of POPG/DMPG
LUVs (see below).
Fig. 5. E¡ect of [NaCl] on the aggregation of DMPG LUVs by
LDL. DMPG liposomes (75 WM) and LDL (6 Wg) were incu-
bated for 60 min in a total volume of one ml and in the pres-
ence of increasing [NaCl] either at 15‡C (E) or 29‡C (F), where-
after absorbance at 470 nm was recorded. Bu¡er was 20 mM
HEPES, 0.1 mM EDTA, pH 7.4. Mean þ S.D. for three sepa-
rate measurements is depicted.
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E¡ects due to changes in bulk pH may have their
origin in altered protonation of apoB. Likewise, in
addition to simple competition of charges, the above
e¡ects of NaCl on the LDL-induced aggregation
could also involve changes in the degree of protona-
tion of the acidic phospholipid [67,68]. In order to
study the latter possibility, bulk pH was kept at 7.4
and the concentration of DMPG in liposomes main-
tained constant at 75 WM while the content of
DMPC in these LUVs was gradually increased. Ac-
cordingly, under these conditions the in£uence of
surface charge density on the aggregation upon vary-
ing the content of DMPC can be resolved. These
experiments were then performed at varying [NaCl]
so as to reveal possible dependency on the protona-
tion state of the acidic phospholipid [67,68]. These
experiments were subsequently repeated maintaining
the total phospholipid concentration constant (at
75 WM) while again gradually varying the DMPC/
DMPG stoichiometry. These two sets of experiments
demonstrated that upon increasing the content of
DMPG in the bilayers, progressively higher [NaCl]
is needed to prevent aggregation by LDL, thus sug-
gesting that an interaction between the protonated
lipid phosphate and LDL is involved. Regardless of
the DMPG/DMPC molar ratio 175 mM NaCl pre-
vented aggregation (data not shown).
3.5. Comparison of di¡erent acidic phospholipids and
the e¡ects of PEG and cholesterol
Subsequently, we compared the aggregation of
vesicles composed of other saturated acidic phospho-
lipids by LDL (Fig. 7). Both DPPG and DMPS were
aggregated by LDL. However, unlike DMPG, they
also aggregated in the gel state, i.e. below their Tm
values at 41.5 and 39‡C, respectively, Interestingly,
vesicles composed of unsaturated acidic phospholip-
ids, egg PG, brain PS, and yeast PI were aggregated
only weakly or not at all by LDL.
Intriguingly, increasing the content of POPG up to
50 mol% in DMPG LUVs caused progressive inhibi-
tion of aggregation prolonging the lag time (Fig.
8A). Analogously to the aggregation of DMPC/
DMPG vesicles at acidic pH, also for POPG/
DMPG LUVs, rapid aggregation was observed at
pH 5.5 (Fig. 8B). Interestingly, at this pH, neat
POPG LUVs were also rapidly aggregated due to
LDL, although the measured increase in A470 was
less than for DMPG or the binary vesicles.
Fig. 7. Aggregation by LDL of LUVs (75 WM) composed of
di¡erent negatively charged phospholipids, DPPG (b), DMPS
(O), yeast PI (+), brain PS (P), and egg PG (8). LUVs were
mixed with LDL (6 Wg/ml) at 29‡C, whereafter changes in ab-
sorbance were recorded as a function of time. Conditions were
otherwise as described in the legend for Fig. 1.
Fig. 6. E¡ect of pH and the content of DMPC on the aggrega-
tion of DMPG LUVs. DMPG liposomes (75 WM) containing
from 0 to 50 mol% DMPC were incubated with LDL (6 Wg/ml)
at pH 5.0 (F), 6.0 (b), 7.0 (O), and pH 7.4 (P) in a total vol-
ume of 1 ml for 60 min at 29‡C while monitoring A470.
Mean þ S.D. for two separate measurements is shown.
BBAMEM 77421 4-8-98
S. Lauraeus et al. / Biochimica et Biophysica Acta 1373 (1998) 147^162 155
To investigate the role of hydration of the phos-
pholipid vesicle surface as an energy barrier for ag-
gregation we included small concentrations (1% by
weight) of the strongly hygroscopic polymer, PEG
into the aqueous phase. This [PEG] did not aggre-
gate either DMPG LUVs or LDL separately (data
not shown). Yet, it decreased the lag time so that
enhanced aggregation of the binary vesicles contain-
ing 50 mol% POPG was clearly evident (Fig. 8C).
Signi¢cant e¡ect due to PEG was observed also at
pH 5.5 (Fig. 8D). Finally, similar e¡ects due to PEG
were evident also for DMPC/DMPG vesicles (data
not shown).
Cholesterol is known to have complex e¡ects on
the phase behaviour and physical properties of phos-
pholipid bilayers (e.g. [70^76]). Therefore, it was of
Fig. 8. Dependency of aggregation on the content of POPG in binary vesicles with DMPG, together with the e¡ects of PEG and
acidic pH. DMPG liposomes (75 WM total phospholipid) as such (E), neat POPG LUVs (a) or binary vesicles containing 15 (b),
35 (8), or 50 mol% (F) of POPG were incubated with LDL (6 Wg/ml) in the absence or presence of PEG (1%, w/w) at 29‡C, where-
after changes in A470 were recorded as a function of time. Conditions were as follows: no PEG, pH 7.4 (A), and no PEG, pH 5.5
(B), PEG (1% by weight) at pH 7.4 (C), and 1% of PEG, pH 5.5 (D).
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interest to investigate also its in£uence on the aggre-
gation of DMPG LUVs by LDL (Fig. 9). The ap-
parent rate of aggregation of DMPG vesicles by
LDL was enhanced by increasing the cholesterol con-
tent XCHOL of the vesicles from 0 to W0.25 (Fig.
9B) or 0.35 (Fig. 9C) whereas at XCHOLW0.5 the
time course for aggregation became biphasic (Fig.
9D).
4. Discussion
The present results reveal liposomes composed of
saturated acidic phospholipids to be aggregated by
human plasma LDL whereas total HDL, HDL2,
HDL3, and VLDL were ine¡ective. The binding of
LDL to liposomes appears to require intact apoB as
tryptic digestion of LDL abolishes its ability to cause
Fig. 9. Aggregation of DMPG/cholesterol LUVs by LDL. DMPG liposomes as such (A) or containing either 25 (B), 35 (C), or
50 mol% (D) of cholesterol were incubated with LDL (6 Wg/ml) up to 90 min at 29‡C while monitoring A470. In order to show the
weak aggregation evident for LUVs containing 50 mol% cholesterol, a di¡erent scale had to be used for the y-axis of (D). The con-
centration of DMPG was maintained constant at 75 WM. Conditions were otherwise as indicated in the legend for Fig. 1. Mean þ S.D.
for two separate measurements is shown.
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aggregation. The involvement of apoB in LDL in the
aggregation of DMPG is compatible also with lack
of aggregation by HDL. Notably, lack of aggrega-
tion of DMPG by VLDL does not contradict the
involvement of apoB in this process as the disposi-
tion of apoB is likely to be di¡erent in VLDL and
LDL. Thus, internalisation of VLDL by ¢broblasts
by the apoB-100 receptor mediated endocytosis and
the subsequent suppression of hydroxymethylglu-
taroyl CoA reductase requires prior catabolic proc-
essing of VLDL to LDL by lipoprotein lipase, as
demonstrated in the in vitro study by Catapano et
al. [78]. Upon oxidation of LDL, the particle net
charge becomes more negative [79,80]. Accordingly,
if the sites of apoB responsible for interaction with
acidic lipids are modi¢ed by oxidation, we may read-
ily expect impaired aggregation.
Preceding aggregation, binding of LDL to the lip-
osome surface must take place. The initial contact of
LDL and LUVs is likely to be mediated by an elec-
trostatic attraction between the positively charged
residues of LDL (apoB) and deprotonated acidic
phospholipids, as indicated by the requirement for
the presence of moderate [NaCl] (Fig. 5). Although
salt-induced changes in LDL cannot be ruled out,
the importance for lipid deprotonation is suggested
by the dependency of the [NaCl] required on the lipid
phase state. The liposome-associated LDL should
then remain capable of further binding with another
liposome, thus liganding two vesicles together. Su⁄-
cient number of LDL particles per LUVs (see below)
should thus result in LDL-mediated cross-links be-
tween liposomes and in aggregate formation. Similar
process has been described for streptavidin mediated
liganding of biotin-lipid containing liposomes into a
3-D maze [81]. Importantly, the LUVs aggregated by
LDL do not merge, as evidenced by the lack of aque-
ous contents mixing. Furthermore, lack of lipid mix-
ing reveals that there is also no hemifusion of the
aggregated bilayers. Using a molecular weight of
2.5U103 kDa for LDL, taking 1000 Aî for the aver-
age diameter of the LUVs, and 75 Aî 2 as the mean
molecular area per DMPG in the liposomes, the stoi-
chiometry of the reactants producing saturating re-
sponses in a typical experiment (i.e. 6 Wg of apoB per
ml) and 75 WM DMPG) is approximately 13 LDLs
per one vesicle. The origin of the lag period observed
for the aggregation remains uncertain at this stage.
One possibility is that a proper number of LDL on
the liposome surface is ¢rst required to overcome
coulombic repulsion between the negatively charged
vesicles. Subsequently, aggregate formation can take
place. The latter would thus be limited by the colli-
sion frequency between the reactants in two proc-
esses, ¢rst LDLs and LUVs, and then LUVs with
bound LDL. This is compatible with the observation
that upon increasing the concentration of either LDL
or DMPG LUVs the lag time becomes shorter.
It could be argued that the aggregation would ac-
tually result from the transfer of DMPG to LDL,
subsequently causing aggregation of the lipoprotein.
Several lines of evidence point out this mechanism to
be unlikely, as follows. First, the transfer of DMPG
is rather slow [82]. Second, inclusion of POPG into
DMPG should not suppress the transfer of DMPG.
However, already at XPOPG = 0.50 a strong inhibition
of LDL-induced aggregation of LUVs is evident.
Third, both DPPG and DPPS should transfer ex-
tremely slowly through the aqueous phase, particu-
larly when in the gel state. However, vesicles com-
posed of these acidic phospholipids are vigorously
aggregated by LDL also when T6Tm.
We have recently provided evidence for two acidic
phospholipid binding sites in cytochrome c, one as-
sociating with deprotonated and the other with pro-
tonated acidic phospholipids [68,83,84]. Our present
results suggest that also LDL associates with both
deprotonated as well as protonated DMPG, as fol-
lows. The augmented aggregation of acidic liposomes
by LDL at more acidic pH could arise from changes
in the protonation of acidic phospholipid. However,
as varying bulk pH also in£uences the protonation of
apoB, the possible role of DMPG protonation can-
not be resolved on the basis of this type of experi-
ments alone. In order to allow for less ambiguous
interpretation of the data, we maintained the bulk
pH constant at 7.4 and varied the surface concentra-
tion of DMPG (XDMPG) by incorporating progres-
sively increasing amounts of DMPC into the
LUVs. These experiments were repeated at varying
[NaCl] and revealed that an increase in [NaCl] is
required to prevent the aggregation of mixed LUVs
containing increased surface concentrations of
DMPG in DMPC. These data are in perfect keeping
with the involvement of an interaction between LDL
and protonated DMPG [67,68].
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At physiological [NaCl] the aggregation of DMPG
is greatly enhanced above the transition temperature
Tm of this phospholipid, whereas strongly attenuated
aggregation was observed for the gel state LUVs.
Accordingly, it was somewhat surprising that LUVs
composed of the acidic, unsaturated phospholipids
brain PS, egg PG, and yeast PI were not aggregated
by LDL. Instead, DMPS and DPPG vesicles were
aggregated, thus suggesting that both an acidic head-
group and saturated fatty acid chains are required.
The involvement of the latter structural feature in
aggregation is intriguing, in particular, as the inclu-
sion of POPG into DMPG LUVs e¡ectively inhibits
their aggregation by LDL. Major changes in the sur-
face charge of the binary DMPG/POPG vesicles at
XPOPG = 0.5 are unlikely. Therefore, impaired electro-
static interaction between LDL and LUVs does not
explain the e¡ect of POPG and other mechanisms
have to be involved. The hydration shell maintained
on phospholipid surfaces [85] contributes a barrier
for peripheral membrane associating ligands, includ-
ing proteins [86]. The requirement for [NaCl] for
aggregation (Fig. 5) may, in addition to the depro-
tonating e¡ect, additionally re£ect dehydration of the
liposome surface [87]. To this end, compared to di-
saturated phospholipids, experimental evidence indi-
cates an enhanced a⁄nity of unsaturated phospho-
lipids for water [88]. Accordingly, increasing contents
of POPG in DMPG LUVs may augment the a⁄nity
of the liposome surface for water to an extent pre-
venting the electrostatic association of LDL with the
acidic headgroups. Role of the phospholipid hydra-
tion layer in retarding the aggregation of vesicles by
LDL is further supported by the ¢nding that both
albumin and PEG already at low concentrations en-
hance the aggregation, i.e. faster aggregation be-
comes evident in their presence. A⁄nity of liposomes
for water is also enhanced at elevated temperatures
[88]. To this end, the role for phospholipid hydration
layer in preventing the aggregation of liposomes by
LDL is further supported by our preliminary obser-
vation on the lack of aggregation of DMPG LUVs at
higher temperatures (i.e. above 38‡C; Lauraeus and
Kinnunen, unpublished results).
Cholesterol is an important modulator of the
physical properties of membranes [70]. Increasing
contents of cholesterol has been veri¢ed by a number
of di¡erent techniques to alter the properties of the
bilayer in a non-linear manner (for a brief review see
[89]), and a superlattice model describing the lateral
distribution of cholesterol in binary membranes has
been recently forwarded [89,90]. Unfortunately, con-
trasting the large number of studies on the properties
of cholesterol/PC bilayers (e.g. [72^75,89^94]) signi¢-
cantly less e¡ort has been devoted to elucidate the
e¡ects of cholesterol on acidic phopholipids. Yet, a
recent study by Borochov et al. [77] shows that the
in£uence of cholesterol on the thermal phase behav-
iour of DMPG is clearly di¡erent from that on
DMPC. We have previously reported cholesterol
(XCHOL = 0.20 or 0.33) to enhance the aggregation
of gel state DMPG liposomes by NaCl, and com-
pared to neat DMPG slightly higher salt concentra-
tions were required for the aggregation of binary lip-
osomes containing cholesterol [71]. At XCHOLW0.25
and 0.35 somewhat accelerated aggregation of the
binary cholesterol/DMPG vesicles by LDL is evi-
dent, whereas at XCHOLW0.50 the kinetics of turbid-
ity increase induced by LDL becomes more complex.
The large scatter of turbidity readings during aggre-
gation evident in the presence of cholesterol is likely
to re£ect variation in the lag time. This is supported
by the smaller variation of the data both in the be-
ginning of the aggregation as well as when the tur-
bidity changes as a function of time have levelled o¡.
Understanding of the physical basis of the observed
e¡ects of cholesterol on the aggregation of DMPG
LUVs by LDL clearly warrants further e¡orts. Inter-
estingly, a recent study shows the binding of blood
proteins to liposomes to be strongly reduced by the
presence of cholesterol [95].
Possible physiological and pathophysiological sig-
ni¢cance of our results remains speculative at
present. Yet, in this context it is worth noticing
that cells maintain a rather stringent ATP-dependent
asymmetry of their plasma membrane lipids [96].
More speci¢cally, the outer monolayer is devoid of
phosphatidylserine which resides instead in the cyto-
plasmic lea£et [97^99]. Interestingly, uptake of LDL
cholesterol by a mechanism not requiring internal-
isation of the lipoprotein has been described for lu-
teal cells [100]. Non-receptor mediated processes in-
volved in the metabolism of LDL are gaining
increasing attention [101]. To this end, although er-
ythrocytes are not capable of receptor mediated en-
docytosis, binding of LDL to these cells has been
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demonstrated. The binding of LDL to erythrocytes
did not depend on the membrane proteins of this cell
and instead an enhanced association became evident
after the treatment of these cells with proteases [38].
It is tempting to speculate that damage and ulti-
mately necrosis of cells in the arterial wall either
due to hypoxia or hypertension may result in loss
of membrane phospholipid asymmetry, which could
further lead to the binding of LDL to PS exposed in
the outer monolayer. Cellular debris is evident upon
histological examination of atheroma [102]. The
present study further demonstrates the association
of LDL to acidic phospholipids to be enhanced by
the protonation of the latter. Accordingly, binding of
LDL to acidic phospholipids should be further aug-
mented at acidic pH, suggested to prevail at sites of
ischaemia and cell injury [103^105]. Formation of
domains [106] enriched in acidic phospholipids
would further enhance this interaction.
Due to the increased risk for atherosclerosis asso-
ciated with oxidation of LDL, the lack of aggrega-
tion of liposomes composed of acidic phospholipids
reported here by this modi¢ed LDL might at ¢rst
appear to be paradoxical. The acidic pH prevailing
inside of lysosomes, together with the rather high
content of acidic phospholipids in these organelles
[107,108], should favour direct association of the in-
ternalised LDL with lysosomal membranes. Accord-
ingly, it is possible, in principle, that this interaction
could contribute to the metabolism of LDL within
lysosomes. Our recent experiments indicate that LDL
may actually fuse with liposomes containing acidic
phospholipids, resulting in the transfer of lipids
from LDL into the liposomal bilayer (Lauraeus
and Kinnunen, unpublished data). If the interaction
of LDL with acidic phospholipids is involved in its
intralysosomal catabolism, impaired processing of
oxidised LDL and elevated risk for atherosclerosis
would be anticipated. Studies exploring these possi-
bilities are now in progress in our laboratory.
Recent evidence suggests the involvement of the
respiratory pathogen Chlamydia pneumoniae strain
TWAR, an obligatory intracellular Gram-negative
bacteria, in the development of coronary heart dis-
ease as well as asymptomatic atherosclerosis (e.g.
[109^112]). However, the mechanistic link connecting
atherosclerosis and C. pneumoniae infection has re-
mained elusive. To this end, the major lipids of
Gram-negative and -positive bacteria are phospha-
tidylethanolamine and PG with a signi¢cant portion
of lipids being saturated [113]. The present data sug-
gest the intriguing possibility that co-aggregation of
LDL and C. pneumoniae could contribute to the de-
velopment of atheroma. This notion is of particular
interest as negatively charged phospholipids have
been shown to form a complex with LDL [48]. Fur-
thermore, this complex is phagocytosed at a higher
rate by macrophages. Studies on the aggregation of
C. pneumoniae by LDL are currently in progress in
our laboratory.
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